MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.phymed.2024.155496

Медицинская библиотека · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024

Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.

Ni Mingxin, Zhang Ye, Sun Zhenzhen, Zhou Qing, Xiao Jun, Zhang Beiping, Lin Jiang, Gong Biao, Liu Fengbin, Meng Fandong, Zheng Guoyin, Wang Yan, Gu Limei, Li Liu, Shen Weixing, Chen Yugen, Liu Yanmei, Li Ling, Ling Tingsheng, Cheng Haibo

Рандомизированное исследованиеМногоцентровое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Colorectal adenoma is benign glandular tumor of colon, the precursor of colorectal cancer. But no pharmaceutical medication is currently available to treat and prevent adenomas.

PURPOSE: To evaluate efficacy of Shenbai Granules, an herbal medicine formula, in reducing the recurrence of adenomas.

STUDY

DESIGN

This multicenter, randomized, double-blind, placebo-controlled clinical trial was conducted by eight hospitals in China.

METHODS

Patients who had received complete polypectomy and were diagnosed with adenomas within the recent 6 months were randomly assigned (1:1) to receive either Shenbai granules or placebo twice a day for 6 months. An annual colonoscopy was performed during the 2-year follow-up period. The primary outcome was the proportion of patients with at least one adenoma detected in the modified intention-to-treat (mITT) population during follow-up for 2 years. The secondary outcomes were the proportion of patients with sessile serrated lesions and other specified polypoid lesions. The data were analyzed using logistic regression.

RESULTS

Among 400 randomized patients, 336 were included in the mITT population. We found significant differences between treatment and placebo groups in the proportion of patients with at least one recurrent adenoma (42.5 % vs. 58.6 %; OR, 0.47; 95 % CI, 0.29-0.74; p = 0.001) and sessile serrated lesion (1.8 % vs. 8.3 %; OR, 0.20; 95 % CI, 0.06-0.72; p = 0.01). There was no significant difference in the proportion of patients developing polypoid lesions (70.7 % vs. 77.5 %; OR, 1.43; 95 % CI, 0.88-2.34; p = 0.15) or high-risk adenomas (9.0 % vs. 13.6 %; OR, 0.63; 95 % CI, 0.32-1.25; p = 0.18).

CONCLUSION

Shenbai Granules significantly reduced the recurrence of adenomas, indicating that they could be an effective option for adenomas. Future studies should investigate its effects in larger patient populations and explore its mechanism of action to provide more comprehensive evidence for the use of Shenbai Granules in adenoma treatment.

Для цитирования: Ni Mingxin, Zhang Ye, Sun Zhenzhen, Zhou Qing, Xiao Jun, Zhang Beiping, Lin Jiang, Gong Biao, Liu Fengbin, Meng Fandong, Zheng Guoyin, Wang Yan, Gu Limei, Li Liu, Shen Weixing, Chen Yugen, Liu Yanmei, Li Ling, Ling Tingsheng, Cheng Haibo. Efficacy and safety of Shenbai Granules for recurrent colorectal adenoma: A multicenter randomized controlled trial.. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2024. DOI: 10.1016/j.phymed.2024.155496.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.